Logo

Whatariff.com

Global Tariffs, Categorized

🇺🇸 United States
🌍 Select Country
📦 2-Acetamidobenzoic acid

2-Acetamidobenzoic acid

HS Code:

📦

Overview

2-Acetamidobenzoic acid, also known as N-acetylanthranilic acid, falls under the HS Code 292429. It is an organic compound primarily used as an intermediate in the synthesis of pharmaceuticals, dyes, and other chemical products. This compound is significant in the production of analgesics and anti-inflammatory drugs, making it a critical component in the pharmaceutical industry. Additionally, it is sometimes monitored due to its potential use in the illicit production of controlled substances.

Total Trade Volume

Approximately $50 million USD

Data from 2022

Source

UN Comtrade Database and ITC Trade Map

Tariff Analysis

Average Rate

5.5% ad valorem

Highest Rate

10% (applied by certain developing countries)

Lowest Rate

0% (under free trade agreements like EU-Japan EPA)

Common Restrictions

  • Import licensing requirements due to potential misuse in controlled substance production
  • Stringent documentation and certification for pharmaceutical intermediates
  • Quota restrictions in some countries for chemical imports

Market Trends

Rising demand in pharmaceutical sector

Increased production and export from key manufacturing hubs like China and India due to growing global demand for analgesics.

2021-2022

Regulatory scrutiny on precursor chemicals

Stricter export controls and monitoring have slowed trade in certain regions, impacting supply chains.

2020-2022

Shift towards sustainable production

Manufacturers are adopting greener synthesis methods, influencing production costs and market competitiveness.

2022

Recent Developments

New Export Controls in China

China introduced tighter export regulations on 2-Acetamidobenzoic acid to prevent illicit use, requiring additional documentation for shipments.

March 2023

Potential delays in supply chains for pharmaceutical manufacturers relying on Chinese exports.

EU Tariff Reduction Agreement

The EU reduced tariffs on pharmaceutical intermediates, including 2-Acetamidobenzoic acid, under a new trade agreement with India.

July 2022

Increased trade flow between India and EU countries, boosting market access for Indian exporters.

US DEA Monitoring Update

The US Drug Enforcement Administration updated its list of monitored chemicals, including 2-Acetamidobenzoic acid, due to its potential misuse.

January 2023

Increased scrutiny and compliance costs for importers and exporters dealing with the US market.